Last updated: May 8, 2019
Sponsor: Peking Union Medical College Hospital
Overall Status: Active - Recruiting
Phase
2
Condition
Bronchitis
Treatment
N/AClinical Study ID
NCT03942926
PB1
Ages > 13 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
plastic bronchitis
pulmonary lymphatic perfusion syndrome demonstrated on 68Ga-NEB positron emissiontomography (PET)
Exclusion
Exclusion Criteria:
Pregnancy and breastfeeding
Severe cardiovascular, hepatic and renal dysfunction
allergy to sirolimus or 68Ga-NEB
Study Design
Total Participants: 10
Study Start date:
May 06, 2019
Estimated Completion Date:
May 05, 2020
Study Description
Connect with a study center
Peking Union Medical College Hospital
Beijing, Beijing 100730
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.